Skip to content

Dokter Nils Sleurs

Active Private limited companyfounded 2020active for 6 yearsBosvlinderstraat 8, 3910 PeltKBO/BCE: BE 0755.592.485

Lifetime

6 annual accounts with figures on one time axis
peak of €169,022 in 2024
€162,390▼ 3.9%
peak of €121,339 in 2024
€118,423▼ 2.4%
peak of €320,083 in 2023
€5,000unchanged
€379,888▼ 27.5%
Board1 name since 2020
1 director
Documentsfilings and deeds
01-06-202660 days before the deadline
2025micro format
Dividend €118,423Debts from €523,898 to €379,888

Key points

from the 2025 annual accounts

Equity

€5,000 from €320,083 in 2023

Equity fell by 98% in 2 years.

Turnover

≈ €290,000 estimated

The micro format states no turnover.

Debts

€379,888 99% of the balance sheet
Financial debts 5%Suppliers 0%Taxes and wages 5%Other 89%

Of this, €31,566 falls due within a year.

Liquidity

11.29 was 1.09 in 2024

Short-term debts fell from €450,120 to €31,566.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 22 to 60 days before the end of the period.

Position in the sector

1.3%

Lower solvency than 94% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dokter Nils Sleurs has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dokter Nils Sleurs. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-10-2020
  • founderdeed of 06-10-2020
Board & ownership

Recent changes

Incorporation Founding capital of €5,000, 5,000 shares · Founded by · appointed as director · published on 06-10-2020 · Gazette deed
First establishment Huisartsenpraktijk Maesveld, Molenstraat 41, Hamont-Achel
All 13 events

Comparable companies

same main activity, similar in size and age
Company
Dokter Nils Sleurs Pelt €384,888 €162,390 1.3% -
Dokter Jonas Wilms Pelt €366,002 €181,584 37.6% -
Huisartsenpraktijk Robijn Maarkedal €378,490 €171,158 25.7% -
DOKTER NICK STEVENS Grimbergen €361,114 €161,587 54.8% -
Dokter Sofie Portier Wetteren €402,531 €162,648 81.2% -
DOKTER ANDRIES ATHALIE - HUISARTS Aalter €362,390 €164,007 97.5% -
DR MARJORIE DUFAUX Profondeville €425,210 €165,724 67.7% -

These companies have the same main activity as Dokter Nils Sleurs: general medical practice (NACE 86210). They are comparable in size and age: total assets between €361,000 and €425,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 02-10-2020Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.309.278.8023930 Hamont-Achel, since 02-10-2020
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€384,888▼ 27.2%
Filing
Filed on 01-06-2026, 60 days before the end of the filing period
Financials

Insights on Dokter Nils Sleurs

Dokter Nils Sleurs files the micro format. That format states no turnover. The gross margin rose from €39,321 in 2020 to €162,390 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dokter Nils Sleurs

What is the company number of Dokter Nils Sleurs?
The company number of Dokter Nils Sleurs is 0755.592.485. The VAT number is the same number with BE in front: BE 0755.592.485.
Where is Dokter Nils Sleurs based?
The registered office is at Bosvlinderstraat 8, 3910 Pelt.Company details
What does Dokter Nils Sleurs do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dokter Nils Sleurs?
Dokter Nils Sleurs is a private limited company (BV).
When was Dokter Nils Sleurs founded?
Dokter Nils Sleurs was founded on 02-10-2020.
Is Dokter Nils Sleurs still active?
Yes, Dokter Nils Sleurs is an active enterprise in the KBO register.
What is the turnover of Dokter Nils Sleurs?
The turnover in financial year 2025 is about €290,000. This figure is estimated from the gross margin of €162,390 and 30 comparable companies (NACE 86210). It probably lies between €240,000 and €370,000.Financials
Is Dokter Nils Sleurs profitable?
In financial year 2025, Dokter Nils Sleurs made a profit of €118,423.
Where can I find the annual accounts of Dokter Nils Sleurs?
Dokter Nils Sleurs filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dokter Nils Sleurs due?
Dokter Nils Sleurs must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.